Hologic Inc (HOLX)

Return on equity (ROE)

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net income (ttm) US$ in thousands 557,100 556,700 744,000 789,500 701,500 466,500 515,100 456,000 484,100 753,000 990,200 1,302,000 1,512,100 1,552,100 1,716,300 1,871,500 2,037,600 1,907,100 1,383,500 1,115,200
Total stockholders’ equity US$ in thousands 4,842,500 4,618,700 4,773,300 5,130,000 4,950,900 4,844,400 4,653,800 5,016,900 5,182,000 5,300,800 5,092,500 4,876,200 4,997,900 4,792,700 4,519,100 4,218,600 3,877,100 3,794,400 3,267,900 2,705,200
ROE 11.50% 12.05% 15.59% 15.39% 14.17% 9.63% 11.07% 9.09% 9.34% 14.21% 19.44% 26.70% 30.25% 32.38% 37.98% 44.36% 52.55% 50.26% 42.34% 41.22%

June 30, 2025 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $557,100K ÷ $4,842,500K
= 11.50%


Peer comparison

Jun 30, 2025

Company name
Symbol
ROE
Hologic Inc
HOLX
11.50%
Becton Dickinson and Company
BDX
6.01%